Beleaguered Avinger, is slashing more jobs. Source: BioSpace

Novartis is not resting on the laurels of having the first-ever-approval for a CAR-T cancer drug, Kymriah. Source: BioSpace

Albert Bourla, 56, has been the Group President of Pfizer’s Innovative Health Business since the beginning of 2016. Source: BioSpace

During the presidential campaign of 2015-2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Source: BioSpace

There's nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace

Noting that biotech stocks have been in "hypergrowth" mode over more than six years, George Budwell, writing for The Motley Fool, looks at three biotech stocks that he would recommend…

Pfizer is planning to hire 200 new staffers and another 200 replacement workers in Michigan. Source: BioSpace

The investment is not part of Gates’ philanthropic Bill & Melinda Gates Foundation and will be followed with another $50 million in a number of start-up ventures working in Alzheimer’s…

After falling short of analysts' expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products. Source: BioSpace

The initial results were presented at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting. Source: BioSpace